Edition:
United Kingdom

Divi's Laboratories Ltd (DIVI.NS)

DIVI.NS on National Stock Exchange of India

1,154.55INR
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
Rs1,154.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
698,099
52-wk High
Rs1,223.00
52-wk Low
Rs612.00

Latest Key Developments (Source: Significant Developments)

Divi's Labs Says US FDA Inspects Unit-I At Telangana From May 14 To May 16
Wednesday, 16 May 2018 

May 16 (Reuters) - Divi's Laboratories Ltd ::SAYS UNIT-I AT CHOUTUPPAL, TELANGANA STATE HAS HAD AN INSPECTION BY US-FDA FROM 14TH MAY TO 16TH MAY.WAS A GENERAL CGMP INSPECTION BY FDA.SAYS INSPECTION HAS BEEN CONCLUDED WITH NO 483 OBSERVATIONS.  Full Article

Divi's Laboratories says US FDA's import alert on unit II at Vishakhapatnam removed‍​
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Divi's Laboratories Ltd ::Says US FDA's import alert 66-40 on co's unit II at Vishakhapatnam has been removed‍​.  Full Article

Divi's Laboratories USFDA completed evaluation of co's corrective actions in response to warning letter
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Divi's Laboratories Ltd :Informed that USFDA completed evaluation of co's corrective actions in response to FDA's warning letter dated April 13.  Full Article

Divi's Labs says U.S.FDA to lift import alert on co's unit-II at Visakhapatnam​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Divi's Laboratories Ltd ::U.S.FDA to lift import alert 66-40 and move to close out warning letter issued to co's unit-II at Visakhapatnam​.  Full Article

India's Divi's Laboratories Sept-qtr profit falls
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Divi's Laboratories Ltd :Sept quarter net profit 2.07 billion rupees versus profit of 2.24 billion rupees year ago.Sept quarter revenue from operations 8.90 billion rupees versus 10.05 billion rupees year ago.Says revenue during current half of year has been impacted due to‍​ FDA import alert, export shipments delay.  Full Article